bq 610 has been researched along with arginyl-glycyl-aspartyl-serine in 1 studies
| Studies (bq 610) | Trials (bq 610) | Recent Studies (post-2010) (bq 610) | Studies (arginyl-glycyl-aspartyl-serine) | Trials (arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (arginyl-glycyl-aspartyl-serine) |
|---|---|---|---|---|---|
| 124 | 1 | 3 | 503 | 0 | 79 |
| Protein | Taxonomy | bq 610 (IC50) | arginyl-glycyl-aspartyl-serine (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 4.17 | |
| Integrin beta-1 | Homo sapiens (human) | 2.2 | |
| Integrin alpha-IIb | Homo sapiens (human) | 4.17 | |
| Integrin alpha-5 | Homo sapiens (human) | 2.2 | |
| Integrin beta | Oryctolagus cuniculus (rabbit) | 5.1 | |
| Glycoprotein IIb | Oryctolagus cuniculus (rabbit) | 5.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, GE; Meininger, GA; Mogford, JE | 1 |
1 other study(ies) available for bq 610 and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
RGDN peptide interaction with endothelial alpha5beta1 integrin causes sustained endothelin-dependent vasoconstriction of rat skeletal muscle arterioles.
Topics: Animals; Antibodies, Blocking; Antigens, CD; Arterioles; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelium, Vascular; Fibronectins; In Vitro Techniques; Integrin alpha5; Integrin beta3; Male; Muscle, Skeletal; Oligopeptides; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Fibronectin; Receptors, Vitronectin; Time Factors; Vasoconstriction | 1997 |